# FDA recall D-0298-2021

> **Jubilant Cadista Pharmaceuticals, Inc.** · Class III · drug recall initiated 2021-02-19.

## Product

Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03

## Reason for recall

Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

## Distribution

USA nationwide, including Puerto Rico.

## Key facts

- **Recall number:** D-0298-2021
- **Recalling firm:** Jubilant Cadista Pharmaceuticals, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-02-19
- **Report date:** 2021-03-10
- **Termination date:** 2022-11-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Salisbury, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0298-2021

## Citation

> AI Analytics. FDA recall D-0298-2021. Retrieved 2026-07-16 from https://api.ai-analytics.org/recall/D-0298-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
